Treatment of Hypertrophic Cardiomyopathy with Atrial Fibrillation in Heart Failure NYHA Class II–IV

Patients with hypertrophic cardiomyopathy and symptomatic heart failure (NYHA class II–IV) face an additional challenge when atrial fibrillation develops or becomes poorly controlled. This combination warrants structured, prompt clinical action.

Clinical Scenario

Heart failure NYHA class II–IV with new-onset or poorly controlled atrial fibrillation. New-onset or poorly controlled AF can exacerbate symptoms in this setting and requires immediate management.

Approach (partial overview)

Management addresses rhythm and rate considerations together with anticoagulation. The complete structured regimen—including sequencing, criteria, and specific options—is available in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1093/eurheartj/ehad194

New-onset or poorly controlled AF can exacerbate symptoms caused by LVOTO and should be managed by prompt restoration of sinus rhythm or ventricular rate control.

View source ↗